Behavioral Health Psychotropics

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC53-10

DiraChart Clinical Reference
Protected section 10 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 10 of 15PreviousNext

9. Weak vs. strong documentation

Weak — does not survive

Why it fails

Strong — defensible

“Resident agitated. PRN given.”

No triggers, no non-pharm attempt, no target symptom, no effect — reads as chemical management.

The escalation model note in §4: behavior data, non-pharm first, indication/target symptom, notification, GDR status, monitoring, and Section E linkage.

“Antipsychotic continued.”

No indication, target symptom, monitoring, or GDR consideration — an unnecessary-drug exposure.

“Antipsychotic at the reduced dose for [indication]; target symptom [x] stable; no EPS/sedation; next GDR review [date].”

“Behaviors this shift.”

No frequency/intensity/trigger — Section E unsupported.

“2 episodes of afternoon agitation, triggered by [x], resolved with redirection and a walk; no PRN needed.”

Section NavigationPart 10 of 15PreviousNext